Alto Neuroscience, Inc. (ANRO)

Form 4 sales, Form 144 notices and lockup dates Pharmaceutical Preparations, in Pharma.

Sales chart range
Log in to watch ANRO
Latest sale
$2.1M
Nov 18 · Unusual
Form 4 sales
2
On record
Form 144 notices
2
Proposed sales
Sold, last 30 days
$2.1M
1 sale by 1 insider
0.2% of shares outstanding
Sold, last 90 days
$5.6M
2 sales by 2 insiders
0.5% of shares outstanding
Next unlock
None
No lockup ahead

Lockups

None ahead
Every lockup on record has ended.
  1. IPO lockupAssumed date
    Jul 30, 2024 845 days ago

    180 days from Feb 1, 2024. The prospectus also states 181 days and 90 days.

    424B4 on sec.gov

Sales by reason

0
Routine
0
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. Nov 18, 2026Unusual

    Michael Conick Hanley Jr., CHIEF OPERATING OFFICER, sold 100% of their holdings

    $2.1M75,000 shares at $27.61

    Filed Nov 18, 2026Form 4

  2. Nov 16, 2026Notice

    Michael Conick Hanley Jr., CHIEF OPERATING OFFICER, filed a notice to sell 75,000 shares

    $2.2M75,000 shares

    Filed Nov 16, 2026Form 144

  3. Sep 30, 2026Unusual

    Nicholas Conrad Smith, PRESIDENT AND CFO, sold 84.9% of their holdings

    $3.6M134,886 shares at $26.45

    Filed Oct 1, 2026Form 4

  4. Sep 29, 2026Notice

    Nicholas Conrad Smith, PRESIDENT AND CFO, filed a notice to sell 134,886 shares

    $3.6M134,886 shares

    Filed Sep 29, 2026Form 144

  5. Jul 31, 2024Lockup ends, assumed

    Lockup assumed to end Jul 31, 2024

    Prospectus filed Feb 5, 2024424B4

  6. Jul 30, 2024Lockup ends, assumed

    Lockup assumed to end Jul 30, 2024

    Prospectus filed Feb 5, 2024424B4

  7. May 1, 2024Lockup ends, assumed

    Lockup assumed to end May 1, 2024

    Prospectus filed Feb 5, 2024424B4

7 of 7

Every transaction

Every transaction on a Form 4 or Form 5 for ANRO
TradedFiledStockNameRoleWhatAmountPriceValueHeld afterSource
Nov 18, 2026Nov 18, 2026ANROMichael Conick Hanley Jr.CHIEF OPERATING OFFICERSold75,000$27.61$2.1M0SEC
Nov 18, 2026Nov 18, 2026ANROMichael Conick Hanley Jr.CHIEF OPERATING OFFICERExercised options75,000$2.35$176k2,896SEC
Oct 2, 2026Oct 5, 2026ANRONicholas Conrad SmithPRESIDENT AND CFOExercised or settledEmployee Stock Option (Right to Buy)55,00057,405SEC
Oct 2, 2026Oct 5, 2026ANRONicholas Conrad SmithPRESIDENT AND CFOExercised options55,000$2.32$128k79,060SEC
Sep 30, 2026Oct 1, 2026ANRONicholas Conrad SmithPRESIDENT AND CFOSold134,886$26.45$3.6M24,060SEC
Sep 30, 2026Oct 1, 2026ANRONicholas Conrad SmithPRESIDENT AND CFOExercised or settledEmployee Stock Option (Right to Buy)134,886121,818SEC
Sep 30, 2026Oct 1, 2026ANRONicholas Conrad SmithPRESIDENT AND CFOExercised options134,886$2.35$317k48,116SEC
May 27, 2026May 29, 2026ANROAndrew Craig MillerDirectorAwardedStock Option (right to buy)26,00026,000SEC
May 14, 2026May 15, 2026ANROAmit EtkinPRESIDENT AND CEOGift400,000833,949SEC
May 12, 2026May 14, 2026ANROHusseini ManjiDirectorAwardedStock Option (right to buy)10,95810,958SEC
May 12, 2026May 14, 2026ANROGwill YorkDirectorAwardedStock Option (right to buy)10,95810,958SEC
May 12, 2026May 14, 2026ANROChristopher Nixon CoxDirectorAwardedStock Option (right to buy)10,95810,958SEC
May 12, 2026May 14, 2026ANRORamiro SanchezDirectorAwardedStock Option (right to buy)10,95810,958SEC
May 12, 2026May 14, 2026ANROAndrew DreyfusDirectorAwardedStock Option (right to buy)10,95810,958SEC
Mar 1, 2026Mar 3, 2026ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBOWithheld for tax2,806$19.69$55k24,060SEC
Mar 1, 2026Mar 3, 2026ANROAmit EtkinPRESIDENT AND CEOWithheld for tax6,227$19.69$123k1.2MSEC
Feb 11, 2026Feb 13, 2026ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBOAwardedEmployee Stock Option (Right to Buy)200,000200,000SEC
Feb 11, 2026Feb 13, 2026ANROAdam SavitzCHIEF MEDICAL OFFICERAwardedEmployee Stock Option (Right to Buy)124,000124,000SEC
Feb 11, 2026Feb 13, 2026ANROAmit EtkinPRESIDENT AND CEOAwardedEmployee Stock Option (Right to Buy)306,000306,000SEC
Feb 11, 2026Feb 13, 2026ANROMichael Conick Hanley Jr.CHIEF OPERATING OFFICERAwardedEmployee Stock Option (Right to Buy)131,000131,000SEC
Jan 2, 2026Jan 6, 2026ANROHusseini ManjiDirectorAwardedEmployee Stock Option (right to buy)4,228$11.82$50k4,228SEC
Jan 2, 2026Jan 6, 2026ANROGwill YorkDirectorAwardedStock Option (right to buy)5,243$11.82$62k5,243SEC
Jan 2, 2026Jan 6, 2026ANROChristopher Nixon CoxDirectorAwardedStock Option (right to buy)7,189$11.82$85k7,189SEC
Jan 2, 2026Jan 6, 2026ANRORamiro SanchezDirectorAwardedStock Option (right to buy)3,806$11.82$45k3,806SEC
Aug 12, 2025Aug 14, 2025ANRORamiro SanchezDirectorAwardedStock Option (right to buy)34,502$0.25$9k3,928SEC
Jul 3, 2025Jul 8, 2025ANROMichael Conick Hanley Jr.CHIEF OPERATING OFFICERReturned to the companyEmployee Stock Option (Right to Buy)321,0000SEC
Jul 3, 2025Jul 8, 2025ANROMichael Conick Hanley Jr.CHIEF OPERATING OFFICERAwardedEmployee Stock Option (Right to Buy)321,000125,000SEC
Jul 3, 2025Jul 8, 2025ANROAdam SavitzCHIEF MEDICAL OFFICERReturned to the companyEmployee Stock Option (Right to Buy)328,1340SEC
Jul 3, 2025Jul 8, 2025ANROAdam SavitzCHIEF MEDICAL OFFICERAwardedEmployee Stock Option (Right to Buy)328,13476,000SEC
Jul 3, 2025Jul 8, 2025ANROAmit EtkinPRESIDENT AND CEOReturned to the companyEmployee Stock Option (Right to Buy)719,9100SEC
Jul 3, 2025Jul 8, 2025ANROAmit EtkinPRESIDENT AND CEOAwardedEmployee Stock Option (Right to Buy)719,910215,000SEC
Jul 3, 2025Jul 8, 2025ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBOReturned to the companyEmployee Stock Option (Right to Buy)506,1240SEC
Jul 3, 2025Jul 8, 2025ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBOAwardedEmployee Stock Option (Right to Buy)506,124135,000SEC
May 13, 2025May 15, 2025ANROHusseini ManjiDirectorAwardedStock Option (right to buy)15,28715,287SEC
May 13, 2025May 15, 2025ANROChristopher Nixon CoxDirectorAwardedStock Option (right to buy)15,28715,287SEC
May 13, 2025May 15, 2025ANROAndrew DreyfusDirectorAwardedStock Option (right to buy)15,28715,287SEC
May 13, 2025May 15, 2025ANROGwill YorkDirectorAwardedStock Option (right to buy)15,28715,287SEC
Feb 5, 2025Feb 7, 2025ANROMichael Conick Hanley Jr.CHIEF OPERATING OFFICERAwardedEmployee Stock Option (Right to Buy)125,000125,000SEC
Feb 5, 2025Feb 7, 2025ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBOAwardedEmployee Stock Option (Right to Buy)135,000135,000SEC
Feb 5, 2025Feb 7, 2025ANROAdam SavitzCHIEF MEDICAL OFFICERAwardedEmployee Stock Option (Right to Buy)76,00076,000SEC
Feb 5, 2025Feb 7, 2025ANROAmit EtkinPRESIDENT AND CEOAwardedEmployee Stock Option (Right to Buy)215,000215,000SEC
Jan 2, 2025Jan 6, 2025ANROGwill YorkDirectorAwardedStock Option (right to buy)19,558$3.17$62k19,558SEC
Jan 2, 2025Jan 6, 2025ANROHusseini ManjiDirectorAwardedStock Option (right to buy)14,195$3.17$45k14,195SEC
Jan 2, 2025Jan 6, 2025ANROChristopher Nixon CoxDirectorAwardedStock Option (right to buy)25,236$3.17$80k25,236SEC
Jul 10, 2024Jul 11, 2024ANROAdam SavitzCHIEF MEDICAL OFFICERBought15,000$12.72$191k39,851SEC
May 20, 2024May 22, 2024ANROMichael Conick Hanley Jr.Chief Operating OfficerAwardedEmployee Stock Option (right to buy)188,000188,000SEC
Mar 28, 2024Apr 1, 2024ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICERBought6,150$16.36$101k26,866SEC
Mar 8, 2024Mar 12, 2024ANROMaha RadhakrishnanDirectorAwardedStock Option (right to buy)32,164$0.50$16k1,590SEC
Mar 1, 2024Mar 5, 2024ANROAdam SavitzCHIEF MEDICAL OFFICERAwardedEmployee Stock Option (Right to Buy)73,00073,000SEC
Mar 1, 2024Mar 5, 2024ANRONicholas Conrad SmithCHIEF FINANCIAL OFFICERAwardedEmployee Stock Option (Right to Buy)90,00090,000SEC
Page 1

Sales, notices and lockups (7)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ANRO
Source
Nov 18, 2026Nov 18, 2026Michael Conick Hanley Jr.ANROCHIEF OPERATING OFFICERForm 4 sale75,000$2.1M100.0%UnusualSEC
Nov 16, 2026Nov 16, 2026Michael Conick Hanley Jr.ANROCHIEF OPERATING OFFICERForm 144 notice75,000$2.2MNoticeSEC
Sep 30, 2026Oct 1, 2026Nicholas Conrad SmithANROPRESIDENT AND CFOForm 4 sale134,886$3.6M84.9%UnusualSEC
Sep 29, 2026Sep 29, 2026Nicholas Conrad SmithANROPRESIDENT AND CFOForm 144 notice134,886$3.6MNoticeSEC
Jul 31, 2024Feb 5, 2024All locked holdersANROLockup expiryLockup ends, assumedSEC
Jul 30, 2024Feb 5, 2024All locked holdersANROLockup expiryLockup ends, assumedSEC
May 1, 2024Feb 5, 2024All locked holdersANROLockup expiryLockup ends, assumedSEC